CoChat

Long‐term lansoprazole treatment for gastro‐oesophageal reflux disease: clinical efficacy and influence on gastric mucosa

Open access
Geboes, K., Dekker, W., Mulder, C. J. J., Nusteling, K., (ON BEHALF OF THE DUTCH STUDY GROUP) · 2001 · Alimentary Pharmacology & Therapeutics
Cited by 47

The DOI matches its Crossref record.

Abstract

Background: Long‐term acid suppression is believed to accelerate atrophic gastritis in Helicobacter pylori ‐positive patients. The influence of long‐term therapy with lansoprazole has not been examined. Aim: To study the clinical and endoscopic efficacy and histological evolution of gastric mucosa during 5 years of maintenance treatment with lansoprazole, 30 mg. Methods: Seventy‐eight patients with endoscopically proven oesophagitis were followed for 5 years. Biopsies taken at the start of the study, during follow‐up and after 5 years were available for 73 patients. Results: The total endoscopic relapse rate was 14.1%. At the start of the study, 34 patients were Helicobacter pylori negative and 39 were Helicobacter pylori positive (two atrophy, 25 antral gastritis, 12 pangastritis). At 5 years, no histological changes had occurred in Helicobacter pylori ‐negative patients. In the Helicobacter pylori ‐positive group, 20 patients developed pangastritis, six had normal histology and one had antral gastritis. Ten of the 12 patients with pangastritis had reduced antral activity. There was no increase in intestinal metaplasia, but there was a tendency towards regression of atrophy in the antrum and towards increased atrophy in the body of the stomach. Conclusions: Maintenance treatment with lansoprazole, 30 mg, is efficacious. The development of glandular atrophy and intestinal metaplasia was not accelerated in Helicobacter pylori ‐positive patients. Helicobacter pylori eradication must be considered only because of the higher cancer risk associated with chronic Helicobacter pylori ‐related gastritis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2001.01105.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 47

Metadata

Authors
Geboes, K., Dekker, W., Mulder, C. J. J., Nusteling, K., & (ON BEHALF OF THE DUTCH STUDY GROUP)
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2001-11-06
Volume
15
Issue
11
Pages
1819-1826
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2072110481
Cited by
47
References
0
FWCI
3.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term lansoprazole treatment for gastro‐oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. https://app.cochat.ai/papers/10.1046/j.1365-2036.2001.01105.x
The paper
Geboes, K., Dekker, W., Mulder, C. J. J., Nusteling, K., & (ON BEHALF OF THE DUTCH STUDY GROUP). (2001). Long‐term lansoprazole treatment for gastro‐oesophageal reflux disease: clinical efficacy and influence on gastric mucosa. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2001.01105.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.